Last reviewed · How we verify
SODIUM PHOSPHATE, DIBASIC
At a glance
| Generic name | SODIUM PHOSPHATE, DIBASIC |
|---|---|
| Drug class | Non-Standardized Plant Allergenic Extract [EPC] |
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1983 |
Approved indications
Common side effects
- Diarrhea
- Nausea
- Stomach pain
- Vomiting
- Bone and joint pain
- Headaches
- Dizziness
- Mental confusion
- Weakness or heaviness of legs
- Unusual tiredness or weakness
- Muscle cramps
- Numbness, tingling, pain or weakness of hands or feet
Serious adverse events
- Seizures
- Fast or irregular heartbeat
- Shortness of breath or troubled breathing
- Low urine output
- Phosphate-induced osteomalacia
Key clinical trials
- A First in Human Trial to Assess the Safety and Immunogenicity of LTB-SA7 Vaccine Against Staphylococcus Aureus. (PHASE1)
- Venetoclax Basket Trial for High Risk Hematologic Malignancies (PHASE1)
- Dexamethasone for Ureteral STent Symptoms (DUSTS) (PHASE1, PHASE2)
- This is a Study to Verify if Periarticular Hip Injection of Corticosteroid After Hip Replacement Reduce the Pain and the Hospitalisation Time (PHASE4)
- Open-Label Extension of EryDex Study IEDAT-04-2022 (PHASE3)
- Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity (NA)
- Testing the Addition of KRT-232 (AMG 232) to Usual Chemotherapy for Relapsed Multiple Myeloma (PHASE1)
- Comparison of Submucosal Dexamethasone and Methylprednisolone in Postoperative Sequelae of Parasymphsis Fractures (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SODIUM PHOSPHATE, DIBASIC CI brief — competitive landscape report
- SODIUM PHOSPHATE, DIBASIC updates RSS · CI watch RSS